scholarly journals miR-7 AND miR-34a sequence cloning and expression in a1235 glioblastoma cell line

2020 ◽  
Vol 3 (2) ◽  
pp. 31-38
Author(s):  
Dora Kolic ◽  
Luka Horvat ◽  
Maja Setinc ◽  
Mariastefania Antica ◽  
Maja Matulic

miRNAs are small non-coding RNAs which have an important role in signalling circuits regulating different cell processes. miR-7 and miR-34a are known as tumour suppressors, and both of them can interfere with cell proliferation, differentiation, apoptosis and migration. We constructed plasmids containing pri-miRNA sequences for these two miRNAs and introduced them into the A1235 glioblastoma cell line. Clones containing increased expression of processed miR-7 and miR-34a were obtained. The proliferation and sensitivity to alkylation agent of transfected cells were similar to those of control cells. Our results indicate that an increase in miR-7 and miR34 expression alone in A1235 glioblastoma cells is not sufficient to change their proliferation or sensitivity to the influence of alkylating agents.

2012 ◽  
Vol 318 (8) ◽  
pp. 925-935 ◽  
Author(s):  
Jonathan Michaud-Levesque ◽  
Nathalie Bousquet-Gagnon ◽  
Richard Béliveau

2021 ◽  
Vol 48 (9) ◽  
pp. 6413-6421
Author(s):  
Marzieh Lotfian Sargazi ◽  
Kobra Bahrampour Juybari ◽  
Mojdeh Esmaeili Tarzi ◽  
Arian Amirkhosravi ◽  
Mohammad Hadi Nematollahi ◽  
...  

2018 ◽  
Vol 14 (4) ◽  
pp. 522-527 ◽  
Author(s):  
Hong Li ◽  
Jian-guo Wu ◽  
Hong-wei Zhang ◽  
Wei Wang ◽  
Yuan-xing Zhang ◽  
...  

2021 ◽  
Vol 22 (11) ◽  
pp. 5557
Author(s):  
Tao-Chieh Yang ◽  
Shih-Jung Liu ◽  
Wei-Lun Lo ◽  
Shu-Mei Chen ◽  
Ya-Ling Tang ◽  
...  

Glioblastoma multiforme (GBM) has remained one of the most lethal and challenging cancers to treat. Previous studies have shown encouraging results when irinotecan was used in combination with temozolomide (TMZ) for treating GBM. However, irinotecan has a narrow therapeutic index: a slight dose increase in irinotecan can induce toxicities that outweigh its therapeutic benefits. SN-38 is the active metabolite of irinotecan that accounts for both its anti-tumor efficacy and toxicity. In our previous paper, we showed that SN-38 embedded into 50:50 biodegradable poly[(d,l)-lactide-co-glycolide] (PLGA) microparticles (SMPs) provides an efficient delivery and sustained release of SN-38 from SMPs in the brain tissues of rats. These properties of SMPs give them potential for therapeutic application due to their high efficacy and low toxicity. In this study, we tested the anti-tumor activity of SMP-based interstitial chemotherapy combined with TMZ using TMZ-resistant human glioblastoma cell line-derived xenograft models. Our data suggest that treatment in which SMPs are combined with TMZ reduces tumor growth and extends survival in mice bearing xenograft tumors derived from both TMZ-resistant and TMZ-sensitive human glioblastoma cell lines. Our findings demonstrate that combining SMPs with TMZ may have potential as a promising strategy for the treatment of GBM.


Author(s):  
Niloufar Sinaei ◽  
Abbas Zare Mirakabadi ◽  
Behzad Behnam ◽  
Azadeh Aminzadeh ◽  
Somayyeh Karami-Mohajeri

Sign in / Sign up

Export Citation Format

Share Document